Abstract
This literature review examines the impact of emerging technologies on diabetes management. The Ambulatory Glucose Profile (AGP) report streamlines the interpretation of continuous glucose monitoring (CGM) data, facilitating medical decision-making. The 670G system demonstrates an overall positive experience, although transitioning to device management can pose challenges. Automated pattern recognition algorithms, as observed in the study by Jensen et al., aid in detecting unrecognized hypoglycaemic events, thereby enhancing glycaemic control. Smart sensors, as per Facchinetti et al., augment CGM accuracy and early alert generation, although false alerts need addressing. Affordability is an issue addressed by Elbalshy et al., where third-party technologies like MiaoMiao provide more cost-effective options. Cost-effectiveness analyses in the studies by Wan and Szadkowska et al. underscore the importance of considering costs and benefits when choosing therapies. The discussion underscores the need for individualised assessment, accounting for quality of life, patient characteristics, and preferences when selecting diabetes management technologies.
References
Boles A, Kandimalla R, Reddy PH. Dynamics of diabetes and obesity: Epidemiological perspective. Biochim Biophys Acta BBA - Mol Basis Dis. 1 de mayo de 2017;1863(5):1026-36.
Chung WK, Erion K, Florez JC, Hattersley AT, Hivert MF, Lee CG, et al. Precision Medicine in Diabetes: A Consensus Report From the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 11 de junio de 2020;43(7):1617-35.
Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 1 de enero de 2022;183:109119.
Dickens LT, Thomas CC. Updates in Gestational Diabetes Prevalence, Treatment, and Health Policy. Curr Diab Rep. 9 de mayo de 2019;19(6):33.
Avilés-Santa ML, Monroig-Rivera A, Soto-Soto A, Lindberg NM. Current State of Diabetes Mellitus Prevalence, Awareness, Treatment, and Control in Latin America: Challenges and Innovative Solutions to Improve Health Outcomes Across the Continent. Curr Diab Rep. 10 de octubre de 2020;20(11):62.
Ovelar HL, Izcurdia C, Quiñonez L, Bejarano R, González S, Paredes B, et al. Caracterización de pacientes con pie diabético en el servicio de urgencias del Hospital de Clínicas, Paraguay. Periodo 2015-2016. Rev Científica Cienc Salud. junio de 2021;3(1):63-70.
Gabetta J, Amarilla A, Rivelli R, Guillén G, Cantero Estigarribia L, Chaparro Báez JA, et al. Control glucémico de pacientes diabéticos en dos Unidades de Salud Familiar, Paraguay, 2018. Estudio piloto. Rev Virtual Soc Paraguaya Med Interna. marzo de 2019;6(1):21-30.
Centurión GO, Echeverría AM, Méreles MAB, Esteche RM, González RMZ. Caracterización clínica de la diabetes gestacional en un hospital materno infantil de Asunción, Paraguay. Ginecol Obstet Rev Of Fed Paraguaya Ginecol Obstet. 31 de mayo de 2023;36-44.
Johnson ML, Martens TW, Criego AB, Carlson AL, Simonson GD, Bergenstal RM. Utilizing the Ambulatory Glucose Profile to Standardize and Implement Continuous Glucose Monitoring in Clinical Practice. Diabetes Technol Ther. junio de 2019;21(S2):S2-17.
Aleppo G, Webb KM. Integrated Insulin Pump and Continuous Glucose Monitoring Technology in Diabetes Care Today: A Perspective of Real-Life Experience With the MinimedTM 670G Hybrid Closed-Loop System. Endocr Pract. 1 de julio de 2018;24(7):684-92.
Prahalad P, Yang J, Scheinker D, Desai M, Hood K, Maahs DM. Hemoglobin A1c Trajectory in Pediatric Patients with Newly Diagnosed Type 1 Diabetes. Diabetes Technol Ther. agosto de 2019;21(8):456-61.
Facchinetti A, Sparacino G, Cobelli C. Signal Processing Algorithms Implementing the “Smart Sensor” Concept to Improve Continuous Glucose Monitoring in Diabetes. J Diabetes Sci Technol. 1 de septiembre de 2013;7(5):1308-18.
Elbalshy M, Boucher S, Galland B, Haszard JJ, Crocket H, Wiltshire E, et al. The MiaoMiao study: can do-it-yourself continuous glucose monitoring technology improve fear of hypoglycaemia in parents of children affected by type 1 diabetes? J Diabetes Metab Disord. 1 de diciembre de 2020;19(2):1647-58.
Wan W, Skandari MR, Minc A, Nathan AG, Zarei P, Winn AN, et al. Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial. Med Decis Making. 1 de noviembre de 2018;38(8):942-53.
Szadkowska A, Baranowska-Jaźwiecka A, Michalak A, Jarosz-Chobot P, Myśliwiec M, Głowińska-Olszewska B, et al. Above 40% of Polish children and young adults with type 1 diabetes achieve international HbA1c target - results of a nationwide cross-sectional evaluation of glycemic control: The PolPeDiab HbA1c study. Pediatr Diabetes. 2021;22(7):1003-13.
Prahalad P, Schwandt A, Besançon S, Mohan M, Obermannova B, Kershaw M, et al. Hemoglobin A1c trajectories in the first 18 months after diabetes diagnosis in the SWEET diabetes registry. Pediatr Diabetes. 2022;23(2):228-36.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2023 Patricia Lorena Martínez López